DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Revance Therapeutics, Inc (NASDAQ: RVNC)

16.46 0.36 (2.24%)

Quote as of


company name or ticker

Recent Quotes

RVNC $16.46 2.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.41
Previous Close $16.10
Daily Range $16.05 - $16.59
52-Week Range $14.02 - $39.86
Market Cap $390.4M
P/E Ratio -3.43
Dividend (Yield) $0.00 (0.0%)
Volume 99,571
Average Daily Volume 231,904
Current FY EPS -$2.87

Sector

Industry

Revance Therapeutics, Inc (RVNC) Description

Revance Therapeutics, Inc Website: http://www.revance.com/

News & Commentary

Biotech 101: Valuing Binary Events

Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.

Revance Therapeutics' (RVNC) CEO Dan Browne on Q3 2014 Results - Earnings Call Transcript

5 Earnings Short-Squeeze Plays

Revance Therapeutics Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Fe

Revance Therapeutics Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Feet Lines

Foam-focused acne fighter Foamix Pharmaceuticals sets terms for $65 million IPO

These 2 Stocks Could Be Winners Because Plenty Of People Want To Look Younger

Revance Therapeutics' (RVNC) CEO Dan Browne on Q2 2014 Results - Earnings Call Transcript

Baron Funds Comments on Revance Therapeutics Inc

US Stock Futures Flat Ahead Of Jobless Claims

This Week in Biotech: Is This the Return of Big M&A?

Merger and acquisition deals and rumors were the talk of the town this week, while three additional clinical and filing updates led to double-digit percentage moves.

See More RVNC News...